NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE13144 Query DataSets for GSE13144
Status Public on Oct 16, 2008
Title Knockdown of CD133 in melanoma cells
Organism Homo sapiens
Experiment type Expression profiling by array
Summary CD133 (Prominin-1) is considered the most important cancer stem cell (CSC)-associated marker identified so far, with increased expression in the CSC fraction of a large variety of human malignancies, including melanoma. Here we investigated the effects of CD133 down-regulation in vitro and in vivo in human metastatic melanoma. The average number of CD133 molecules on the cell surface of FEMX-I melanoma cells was decreased by 8.7-fold and 1.8-fold using two different short hairpin RNAs. Down-regulation of CD133, confirmed by immunocytochemistry, Western blotting, microarray analysis and RT-PCR, resulted in slower cell growth, reduced cell motility, and decreased capacity to form spheroids under stem cell-like growth conditions. Clonal analysis revealed that the reduction in growth rate was proportional to the extent of CD133 down-regulation. Monoclonal antibodies directed against two different epitopes of the CD133 protein induced a specific, dose-dependent cytotoxic effect in FEMX-I cells. The down-regulation of CD133 severely reduced the capacity of the cells to metastasize, particularly to the spinal cord. In the CD133 downregulated cells, microarray analysis revealed expression changes for only 143 annotated genes (76 up- and 67 down-regulated). Ten of the 76 up-regulated genes coded for Wnt inhibitors, suggesting an interaction between CD133 and the canonical Wnt pathway. We conclude that CD133, in addition to its role as a cancer stem cell marker, is an important therapeutic target for metastatic melanoma and, potentially, for other CD133-expressing cancer types.
 
Overall design Two control experiments and two CD133 knockdown experiments.
 
Contributor(s) Rappa G, Fodstad O, Lorico A
Citation(s) 18802032
Submission date Oct 09, 2008
Last update date May 25, 2012
Contact name Keith S Hoek
E-mail(s) keith.hoek@usz.ch
URL http://www.jurmo.ch/work.html
Organization name Currently unaffilliated
Street address private
City Zürich
ZIP/Postal code 8004
Country Switzerland
 
Platforms (1)
GPL7430 MCI Human HEEBOChip 42k oligo array
Samples (4)
GSM329155 FEMX-I control melanoma cells
GSM329195 FEMX-I control melanoma cells (II)
GSM329201 FEMX-I melanoma cells CD133 knockdown
Relations
BioProject PRJNA109579

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE13144_RAW.tar 3.9 Mb (http)(custom) TAR (of GPR)
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap